Thus, further experiments are necessary to examine whether alterations in WHSC1 dosage impact the Wnt signaling pathway, potentially leading to abnormal NCC migration and the spectrum of defects observed in WHS. This evidence concerns the gene NSD2 and Wolf-Hirschhorn syndrome.